4x less tissue slippage for the most precise transection. Uniquely designed for better grip to provide the least tissue slippage§ for the most precise transection. Proprietary Gripping Surface Technology provides superior tissue grip without additional trauma during firing. This means you can transect more of the tissue you intended - especially in very thick tissue - with each firing.
GST60B ETHELON
Control Tissue Slippage During Firing
4x less tissue slippageâ? for the most precise transection. Uniquely designed for better gripâ?¡ to provide the least tissue slippage§ for the most precise transection. Proprietary Gripping Surface Technology provides superior tissue gripâ without additional trauma during firing. This means you can transect more of the tissue§ you intended - especially in very thick tissue - with each firing.
ADVALON Suture is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic, and neurological procedures.
ADVALON Suture elicits a minimal acute inflammatory reaction in tissue, which is followed by a gradual encapsulation of the suture by fibrous connective tissue. While nylon is not absorbed, progressive hydrolysis of the nylon in vivo may result in gradual loss of tensile strength over time.
Due to the gradual loss of tensile strength which may occur over prolonged periods in vivo, nylon suture should not be used where permanent retention of tensile strength is required.
Features
Benefits
Excellent pliability
Provides exceptional handling and knot tying properties
Monofilament construction
Easy passage through tissue with low frictional co-efficient
Inert polymer
Ideal for infected wound closure Suture of choice for desired cosmetic outcomes
Excellent elasticity
Superior tactile feedback to the surgeon, minimal suture breakage
Tyvek packaging
Durable protection & long lasting sterility
Gamma radiation of sterilization
Environmental friendly & less hazardous
300 Series premium cutting needles
Strong & sharp needles for minimal bending & desired cosmetic outcomes
Durable silicon coated needles
Significantly enhanced initial and multi-pass penetration
Ribbed bodied needles
Better grasping & superior needle control
ADVACRYL Suture is synthetic absorbable sterile surgical suture composed of a copolymer made from 90% Glycolide and 10% L-lactide. Braided ADVACRYL Suture is coated with a mixture composed of Poly (Glycolide-co-lactide) (Glacomer 37) and calcium stearate. The suture is colored violet to increase visibility and is also available undyed.
The advanced extrusion process of copolymer, the exclusive braiding process and coating system, give ADVACRYL:
ADVACRYL Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological tissues.
ADVACRYL Suture being absorbable, should not be used where permanent support of tissue is required.
Progressive loss of tensile strength and eventual absorption of ADVACRYL Suture occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass.
NEW XIENCE SIERRA STENT DESIGN
The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile1 and greater post-dilatation expansion
NEW STENT DELIVERY SYSTEM FOR COMPLEX CASES
Design innovations built to provide the flexibility, crossability, and pushability needed for even the most complex cases.
The XIENCE V®, XIENCE nano®, XIENCE PRIME®, XIENCE PRIME® LL, XIENCE Xpedition®, XIENCE Xpedition® SV and XIENCE Xpedition® LL , XIENCE Alpine®, and XIENCE SierraTM (XIENCE Family) of Everolimus Eluting Coronary Stents on the MULTI-LINK VISION® or MULTI-LINK MINI VISION® Delivery System
INDICATIONS
The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length â?¤ 32 mm) with reference vessel diameters of â?¥ 2.25 mm to â?¤ 4.25 mm. In addition, the XIENCE Sierra stent system is indicated for treating de novo chronic total coronary occlusions.
CONTRAINDICATIONS
The XIENCE Sierra stent system is contraindicated for use in:
Patients who cannot tolerate, including allergy or hypersensitivity to, procedural anticoagulation or the post-procedural antiplatelet regimen.
Patients with hypersensitivity or contraindication to everolimus or structurally related compounds, or known hypersensitivity to stent components (cobalt, chromium, nickel, tungsten, acrylic, fluoropolymers), or with contrast sensitivity.
WARNINGS
It is not recommended to treat patients having a lesion that prevent complete inflation of an angioplasty balloon.
Judicious patient selection is necessary because the use of this device carries the associated risk of stent thrombosis, vascular complications, and/or bleeding events.
This product should not be used in patients who are not likely to comply with the recommended antiplatelet therapy.
ADVAPD Suture is synthetic absorbable sterile surgical suture composed of a copolymer made from polyester and Polydioxanone.
The advanced extrusion process of the molecule of Polydioxanone gives ADVAPD:
ADVAPD Suture is indicated for use in soft tissue approximation, including use in pediatric cardiovascular tissue where growth is expected to occur and ophthalmic surgery. PDS II Suture is not indicated in adult cardiovascular surgery, microsurgery and neural tissue.
ADVAPD Suture is particularly useful where the combination of an absorbable suture and extended wound support (up to six weeks) is desirable.
ADVAPD Suture, being absorbable, is not to be used where prolonged (beyond six weeks) approximation of tissues under stress is required and is not to be used in conjunction with prosthetic devices (i.e. heart valves or synthetic grafts). Suture absorption occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass.
